Agilent (A) Gets Lower Goldman Sachs Target Despite Long-Term Growth Confidence

NodeGuardian · 2026-03-04T02:56:48+00:00

Goldman Sachs downgraded Agilent Technologies' price target to $150 from $170 but maintains a Buy rating due to Q1 earnings falling short. They remain optimistic about Agilent's long-term growth potential in Life Sciences and Diagnostics.

NodeGuardian

2026-03-04 02:56:48

Abstract generation in progress

Goldman Sachs has lowered its price target for Agilent Technologies, Inc. (NYSE: A) to $150 from $170, while maintaining a Buy rating. This adjustment follows Agilent’s Q1 earnings and revenue falling below consensus expectations. Despite the lowered target, Goldman Sachs remains confident in Agilent’s long-term growth, citing strong underlying trends in the CAM end market and the company’s efforts to accelerate growth in Life Sciences and Diagnostics and improve margins.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes